JP2011102272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011102272A5 JP2011102272A5 JP2009258356A JP2009258356A JP2011102272A5 JP 2011102272 A5 JP2011102272 A5 JP 2011102272A5 JP 2009258356 A JP2009258356 A JP 2009258356A JP 2009258356 A JP2009258356 A JP 2009258356A JP 2011102272 A5 JP2011102272 A5 JP 2011102272A5
- Authority
- JP
- Japan
- Prior art keywords
- yangambin
- pinoresinol
- sesamin
- group
- silvathesmin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 5
- PEUUVVGQIVMSAW-RZTYQLBFSA-N (+)-Eudesmin Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(OC)=CC=3)[C@@H]2CO1 PEUUVVGQIVMSAW-RZTYQLBFSA-N 0.000 claims 4
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 claims 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 claims 3
- PEUUVVGQIVMSAW-UHFFFAOYSA-N Diaeudesmin Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(OC)=CC=3)C2CO1 PEUUVVGQIVMSAW-UHFFFAOYSA-N 0.000 claims 3
- HRLFUIXSXUASEX-RZTYQLBFSA-N Yangambin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(OC)=C(OC)C=3)CO2)=C1 HRLFUIXSXUASEX-RZTYQLBFSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 claims 3
- HRLFUIXSXUASEX-UHFFFAOYSA-N lirioresinol-beta-dimethyl ether Natural products COC1=C(OC)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(OC)=C(OC)C=3)CO2)=C1 HRLFUIXSXUASEX-UHFFFAOYSA-N 0.000 claims 3
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 claims 3
- 235000007221 pinoresinol Nutrition 0.000 claims 3
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 claims 3
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229960000956 coumarin Drugs 0.000 claims 2
- 235000001671 coumarin Nutrition 0.000 claims 2
- 229930186916 eudesmin Natural products 0.000 claims 2
- 210000001365 lymphatic vessel Anatomy 0.000 claims 2
- -1 silvathesmin Chemical compound 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- WEKCEGQSIIQPAQ-IRBNZIFYSA-N (+)-syringaresinol beta-D-glucoside Chemical compound COC1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=C1 WEKCEGQSIIQPAQ-IRBNZIFYSA-N 0.000 claims 1
- PEUUVVGQIVMSAW-DJDZNOHASA-N (3r,3as,6r,6as)-3,6-bis(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@H](CO[C@H]2C=3C=C(OC)C(OC)=CC=3)[C@H]2CO1 PEUUVVGQIVMSAW-DJDZNOHASA-N 0.000 claims 1
- TWORTZAXDSRCIT-UHFFFAOYSA-N 1-(2-hydroxyethyl)cyclohexane-1,4-diol Chemical compound OCCC1(O)CCC(O)CC1 TWORTZAXDSRCIT-UHFFFAOYSA-N 0.000 claims 1
- CPJKKWDCUOOTEW-YJPXFSGGSA-N 4-[(3s,3ar,6r,6ar)-6-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O)=CC=3)[C@@H]2CO1 CPJKKWDCUOOTEW-YJPXFSGGSA-N 0.000 claims 1
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims 1
- FFDULTAFAQRACT-JSGUJALWSA-N Eleutheroside E Chemical compound COC1=CC([C@@H]2[C@@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-JSGUJALWSA-N 0.000 claims 1
- FFDULTAFAQRACT-MWBGVTEFSA-N Eleutheroside E Natural products COc1cc(cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H]3OC[C@H]4[C@H]3CO[C@@H]4c5cc(OC)c(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(OC)c5 FFDULTAFAQRACT-MWBGVTEFSA-N 0.000 claims 1
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- MKRWWSNBWNFVDX-UHFFFAOYSA-N eleutheroside E1 Natural products COC1=CC(C(C)=O)=CC=C1OC1C(O)C(O)C(O)C(COC2C(C(O)(CO)CO2)O)O1 MKRWWSNBWNFVDX-UHFFFAOYSA-N 0.000 claims 1
- 230000035800 maturation Effects 0.000 claims 1
- 238000010606 normalization Methods 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- CPJKKWDCUOOTEW-UHFFFAOYSA-N sylvatesmin Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(O)=CC=3)C2CO1 CPJKKWDCUOOTEW-UHFFFAOYSA-N 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009258356A JP5274431B2 (ja) | 2009-11-11 | 2009-11-11 | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009258356A JP5274431B2 (ja) | 2009-11-11 | 2009-11-11 | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011102272A JP2011102272A (ja) | 2011-05-26 |
| JP2011102272A5 true JP2011102272A5 (enExample) | 2012-12-27 |
| JP5274431B2 JP5274431B2 (ja) | 2013-08-28 |
Family
ID=44192783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009258356A Active JP5274431B2 (ja) | 2009-11-11 | 2009-11-11 | Tie2活性化剤、血管の成熟化、正常化又は安定化剤、リンパ管安定化剤並びにしわ防止・改善剤及びむくみ改善・予防剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5274431B2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2772255B1 (en) * | 2011-10-27 | 2019-05-08 | Amorepacific Corporation | Composition comprising syringaresinol for improving the skin |
| KR102337308B1 (ko) * | 2014-12-05 | 2021-12-09 | (주)아모레퍼시픽 | (-)-유데스민을 함유하여 피부 노화를 방지 또는 개선하는 조성물 |
| KR102323455B1 (ko) * | 2015-03-20 | 2021-11-09 | (주)아모레퍼시픽 | 피부미백 증진용 화장료 조성물 |
| JP6866354B2 (ja) * | 2016-04-18 | 2021-04-28 | サントリーホールディングス株式会社 | Tie2活性化用組成物 |
| JP7244024B2 (ja) * | 2018-06-25 | 2023-03-22 | 学校法人近畿大学 | ニコチン摂取の影響による血管壁のコラーゲン分解防止剤 |
| JP6712740B1 (ja) | 2019-03-25 | 2020-06-24 | 学校法人東海大学 | Tie2陽性幹/前駆細胞を含む細胞集団の培養方法およびその利用 |
| WO2021220997A1 (ja) | 2020-04-27 | 2021-11-04 | 学校法人東海大学 | 軟骨由来Tie2陽性細胞を含む細胞集団の培養方法およびその利用 |
| CN113398113A (zh) * | 2021-06-23 | 2021-09-17 | 陕西中医药大学 | 松脂素在制备抑制血栓形成的药物中的用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3310649B2 (ja) * | 2000-03-16 | 2002-08-05 | 株式会社ファンケル | 食品組成物 |
| CA2448044A1 (en) * | 2001-06-02 | 2002-12-12 | Kolon Ind. Inc. | Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| JP4901025B2 (ja) * | 2001-06-22 | 2012-03-21 | 株式会社ナリス化粧品 | エラスターゼ阻害剤 |
| JP4901024B2 (ja) * | 2001-06-22 | 2012-03-21 | 株式会社ナリス化粧品 | 8−OHdG(8−ハイドロキシデオキシグアノシン)産生抑制剤 |
| JP2003038140A (ja) * | 2001-07-31 | 2003-02-12 | I-Deal Coms Kk | エゾウコギを含む栄養飲料 |
| JP2004123563A (ja) * | 2002-09-30 | 2004-04-22 | Iskra Ind Co Ltd | 沙棘から得られた果実油と他の生薬の抽出成分を含む化粧料 |
| CN1304542C (zh) * | 2004-10-12 | 2007-03-14 | 李恒 | 辛夷(望春花)油 |
| JP2006111545A (ja) * | 2004-10-13 | 2006-04-27 | Nippon Menaade Keshohin Kk | グルタチオンレダクターゼ活性増強剤 |
| JP4732854B2 (ja) * | 2005-10-31 | 2011-07-27 | 一丸ファルコス株式会社 | ペルオキシソーム増殖剤応答性受容体活性化剤 |
| JP5122752B2 (ja) * | 2006-03-23 | 2013-01-16 | 株式会社ナリス化粧品 | メイラード反応阻害剤 |
| JP2008001617A (ja) * | 2006-06-21 | 2008-01-10 | Nippon Fine Chem Co Ltd | リポ酸含有化粧料及び皮膚外用剤 |
| WO2008126587A1 (ja) * | 2007-03-15 | 2008-10-23 | Suntory Holdings Limited | 抗疲労剤 |
| JP2009149626A (ja) * | 2007-11-27 | 2009-07-09 | Lion Corp | 皮膚バリア機能改善剤、及びそれを利用した外用剤組成物 |
| JP2010001267A (ja) * | 2008-06-23 | 2010-01-07 | Ctc−Lanka株式会社 | 植物抽出物 |
-
2009
- 2009-11-11 JP JP2009258356A patent/JP5274431B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011102272A5 (enExample) | ||
| CR20210578A (es) | Derivados de ácido itacónico y usos de estos en el tratamiento de una enfermedad inflamatoria asociada con una respuesta inmunotaria indeseable | |
| WO2013074386A3 (en) | Hcv ns3 protease inhibitors | |
| WO2008051477A3 (en) | Hcv ns3 protease inhibitors | |
| JP2011511817A5 (enExample) | ||
| EA201290498A1 (ru) | Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения | |
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| JP2010501534A5 (enExample) | ||
| MX2011006631A (es) | Inhibidores de proteasa ns3 del virus hcv. | |
| JP2008534695A5 (enExample) | ||
| JP2007523049A5 (enExample) | ||
| EP2507756A4 (en) | PROCESSING OF ITEMS WITH CUSTOMIZABLE VALUE | |
| WO2008051514A3 (en) | Hcv ns3 protease inhibitors | |
| WO2008051475A3 (en) | Hcv ns3 protease inhibitors | |
| EA200702493A1 (ru) | Соединения и способы лечения или предотвращения флавивирусных инфекций | |
| BRPI0909333A2 (pt) | derivado de espiroindolinona | |
| WO2012019299A9 (en) | Hepatitis c inhibitor compounds | |
| ATE507214T1 (de) | Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität | |
| JP2009055850A5 (enExample) | ||
| JP2011509325A5 (enExample) | ||
| TW200504042A (en) | Combretastatin derivatives with cytotoxic action | |
| JP2009532412A5 (enExample) | ||
| JP2012525422A5 (enExample) | ||
| JP2011522850A5 (enExample) | ||
| WO2011028915A3 (en) | Platelet aggregation inhibitors |